Literature DB >> 19021241

The performance of multiple imputation for missing covariate data within the context of regression relative survival analysis.

Roch Giorgi1, Aurélien Belot, Jean Gaudart, Guy Launoy.   

Abstract

Relative survival assesses the effects of prognostic factors on disease-specific mortality when the cause of death is uncertain or unavailable. It provides an estimate of patients' survival, allowing for the effects of other independent causes of death. Regression-based relative survival models are commonly used in population-based studies to model the effects of some prognostic factors and to estimate net survival. Most often, studies focus on routinely collected prognostic factors for which the proportion of missing values is usually low (around 5 per cent). However, in some cases, additional factors are collected with a greater proportion of missingness. In the present article, we systematically assess the performance of multiple imputation in regression analysis of relative survival through a series of simulation experiments. According to the assumptions concerning the missingness mechanism (completely at random, at random, and not at random) and the missingness pattern (monotone, non-monotone), several strategies were considered and compared: all cases analysis, complete cases analysis, missing data indicator analysis, and multiple imputation by chained equations (MICE) analysis. We showed that MICE performs well in estimating the hazard ratios and the baseline hazard function when the missing mechanism is missing at random (MAR) conditionally on the vital status. In the situations where the missing mechanism was not MAR conditionally on vital status, complete case behaves consistently. As illustration, we used data of the French Cancer Registries on relative survival of patients with colorectal cancer. Copyright 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 19021241     DOI: 10.1002/sim.3476

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  11 in total

1.  When Is a Complete-Case Approach to Missing Data Valid? The Importance of Effect-Measure Modification.

Authors:  Rachael K Ross; Alexander Breskin; Daniel Westreich
Journal:  Am J Epidemiol       Date:  2020-12-01       Impact factor: 4.897

2.  Comparative assessment of the safety and effectiveness of radiofrequency ablation among elderly medicare beneficiaries with hepatocellular carcinoma.

Authors:  Nader N Massarweh; James O Park; Raymond S W Yeung; David R Flum
Journal:  Ann Surg Oncol       Date:  2011-09-27       Impact factor: 5.344

3.  Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery.

Authors:  Nader N Massarweh; Chung-Yuan Hu; Y Nancy You; Brian K Bednarski; Miguel A Rodriguez-Bigas; John M Skibber; Scott B Cantor; Janice N Cormier; Barry W Feig; George J Chang
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

4.  Subsample ignorable likelihood for accelerated failure time models with missing predictors.

Authors:  Nanhua Zhang; Roderick J Little
Journal:  Lifetime Data Anal       Date:  2014-08-05       Impact factor: 1.588

5.  Adequacy of the National Quality Forum's Colon Cancer Adjuvant Chemotherapy Quality Metric: Is 4 Months Soon Enough?

Authors:  Nader N Massarweh; Alex B Haynes; Yi-Ju Chiang; George J Chang; Y Nancy You; Barry W Feig; Janice N Cormier
Journal:  Ann Surg       Date:  2015-08       Impact factor: 12.969

6.  Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Matthew J Budoff; Rebekah Young; Victor A Lopez; Richard A Kronmal; Khurram Nasir; Roger S Blumenthal; Robert C Detrano; Diane E Bild; Alan D Guerci; Kiang Liu; Steven Shea; Moyses Szklo; Wendy Post; Joao Lima; Alain Bertoni; Nathan D Wong
Journal:  J Am Coll Cardiol       Date:  2013-03-26       Impact factor: 24.094

7.  Dealing with missing data in the Center for Epidemiologic Studies Depression self-report scale: a study based on the French E3N cohort.

Authors:  Noémie Resseguier; Hélène Verdoux; Roch Giorgi; Françoise Clavel-Chapelon; Xavier Paoletti
Journal:  BMC Med Res Methodol       Date:  2013-02-21       Impact factor: 4.615

8.  Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role?

Authors:  Sandra Le Guyader-Peyrou; Sébastien Orazio; Olivier Dejardin; Marc Maynadié; Xavier Troussard; Alain Monnereau
Journal:  Haematologica       Date:  2016-12-01       Impact factor: 9.941

9.  Variation in treatment and survival of older patients with non-metastatic breast cancer in five European countries: a population-based cohort study from the EURECCA Breast Cancer Group.

Authors:  Marloes G M Derks; Esther Bastiaannet; Mandy Kiderlen; Denise E Hilling; Petra G Boelens; Paul M Walsh; Elizabeth van Eycken; Sabine Siesling; John Broggio; Lynda Wyld; Maciej Trojanowski; Agnieszka Kolacinska; Justyna Chalubinska-Fendler; Ana Filipa Gonçalves; Tomasz Nowikiewicz; Wojciech Zegarski; Riccardo A Audisio; Gerrit-Jan Liefers; Johanneke E A Portielje; Cornelis J H van de Velde
Journal:  Br J Cancer       Date:  2018-06-07       Impact factor: 7.640

Review 10.  Individual participant data meta-analysis of intervention studies with time-to-event outcomes: A review of the methodology and an applied example.

Authors:  Valentijn M T de Jong; Karel G M Moons; Richard D Riley; Catrin Tudur Smith; Anthony G Marson; Marinus J C Eijkemans; Thomas P A Debray
Journal:  Res Synth Methods       Date:  2020-02-06       Impact factor: 5.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.